Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Clinical Immunology

The Biology of IMD107: A Tissue-Level Vulnerability

At a Glance

IMD107 is a rare inherited condition caused by one nonworking OTULIN copy. It can leave certain skin and lung tissue cells vulnerable to Staphylococcus aureus alpha-toxin, causing severe tissue injury even when routine white blood cell counts are normal.

To understand Immunodeficiency 107 (IMD107), it helps to look at your body’s defenses not just as circulating immune cells, but as structural tissue layers. It can be jarring to be told you have an immunodeficiency when your routine tests are normal, but in IMD107, routine leukocyte counts are typically normal, while a specific vulnerability exists in the cells making up your skin and lungs [1][2].

The Role of the OTULIN Gene

At the heart of this condition is a change in a single gene called OTULIN. Most people have two working copies of this gene, which provides instructions for a protein that helps regulate cellular function and inflammation [1].

In IMD107, you have a heterozygous mutation, meaning one copy of the gene is non-functional (also called a loss-of-function mutation) [3]. Having only one working copy is not enough for certain cells to regulate themselves properly. This leads to an accumulation of certain substances inside your skin cells (called dermal fibroblasts):

  1. Linear Ubiquitin: A type of protein chain that builds up when OTULIN is reduced [1].
  2. Caveolin-1 Accumulation (Research Hypothesis): In laboratory settings, researchers have hypothesized that an accumulation of Caveolin-1 creates a vulnerable interaction site for bacterial toxins on the cell surface. This is a research finding to explain the mechanism, not a validated clinical test [1][4].

Why Staph is the Primary Threat

While your immune system can fight off most germs, it has a specific weakness against a bacterium called Staphylococcus aureus (“Staph”). This bacterium produces a substance called alpha-toxin [1][2].

In a typical person, the skin cells have enough OTULIN to resist this toxin. But because of the cellular changes in IMD107, certain tissue cells are unusually vulnerable to alpha-toxin mediated injury [1]. This is why the condition leads to necrosis (tissue death) even when your white blood cell counts are unremarkable [1][3].

Inheritance and Incomplete Penetrance

IMD107 follows an autosomal dominant inheritance pattern. This means that only one altered copy of the gene is needed to be at risk for the condition [3]. However, doctors describe IMD107 as having incomplete penetrance [1].

Incomplete penetrance refers to the proportion of variant carriers who actually develop a clinical phenotype. You might carry the gene change but never experience a severe infection. Researchers hypothesize this may partly be due to naturally occurring anti-alpha-toxin antibodies acting as a buffer; however, testing antibody levels is not a validated clinical tool to reassure a carrier or determine treatment [1].

Distinguishing IMD107 from Other Conditions

Because IMD107 is so rare, it is often confused with other genetic or immune issues. Your doctor will likely look at these “look-alikes”:

ORAS (OTULIN-Related Autoinflammatory Syndrome)

It is easy to confuse IMD107 with ORAS because they involve the same gene, but they are very different:

  • ORAS occurs when both copies of the OTULIN gene are mutated (biallelic) [4][5].
  • ORAS causes severe, body-wide inflammation starting at birth, including constant fevers, diarrhea, and joint pain [5][6].
  • IMD107 usually only involves targeted tissue injury triggered by an infection or trauma, rather than constant systemic inflammation [1].

Cri-du-chat Syndrome (5p Deletion)

The OTULIN gene is located on a specific part of chromosome 5 (called the 5p region). Some individuals are born missing a large segment of this chromosome, a condition called Cri-du-chat syndrome [1]. Because a large chromosomal deletion has many genes and a different clinical context, the risk is not automatically equivalent, but a deletion encompassing OTULIN may warrant genetics and immunology review for staphylococcal vulnerability [1].

Other Immune Mimics

  • Chronic Granulomatous Disease (CGD): Like IMD107, CGD causes severe Staph infections. However, in CGD, the problem is in the white blood cells (they can’t produce the reactive oxygen needed to kill germs), whereas in IMD107, the routine blood cells are typical and the structural cells are the problem [1][7].
  • Hyper-IgE Syndrome (HIES): People with HIES also get severe Staph skin abscesses. However, HIES usually involves very high levels of an antibody called IgE and distinctive clinical features that aren’t seen in IMD107 [8][9].

Understanding these biological differences helps your care team confirm that IMD107 is the correct diagnosis and ensures that your treatment focuses appropriately on protecting your vulnerable tissues [1][2].

Common questions in this guide

What causes Immunodeficiency 107, or IMD107?
IMD107 is linked to a change that disables one copy of the OTULIN gene. This can leave certain skin and lung tissue cells more vulnerable to Staphylococcus aureus alpha-toxin, which may cause tissue death even when routine white blood cell counts are normal.
Why can Staph infections become severe in IMD107 if blood counts are normal?
The main weakness in IMD107 is in certain structural tissue cells rather than in the number of circulating white blood cells. Staphylococcus aureus produces alpha-toxin, and affected cells may be unusually vulnerable to toxin-related injury and necrosis.
Is IMD107 the same as OTULIN-related autoinflammatory syndrome?
No. IMD107 usually involves one altered OTULIN copy and causes targeted tissue injury during infection or trauma, whereas OTULIN-related autoinflammatory syndrome generally involves changes in both copies and causes early, widespread inflammation such as persistent fever, diarrhea, and joint pain.
What does incomplete penetrance mean for someone with an OTULIN variant?
It means that not every person who carries the variant develops severe IMD107-related infection or tissue injury. Researchers have proposed that naturally occurring antibodies against alpha-toxin may help explain this difference, but antibody testing is not a validated way to predict risk or choose treatment.
Can IMD107 run in families, and should children or siblings be tested?
Because one altered OTULIN copy can be enough to create risk, the variant may be passed through a family. Children and siblings should ask a genetics professional whether testing is appropriate, even if they have never had a severe infection.
How is IMD107 distinguished from chronic granulomatous disease or Hyper-IgE syndrome?
Chronic granulomatous disease primarily affects white blood cells’ ability to kill germs, while IMD107 involves vulnerability in certain tissue cells despite typical routine blood counts. Hyper-IgE syndrome can also cause severe Staph skin abscesses, but it usually includes very high IgE levels and other distinctive features.
Could a 5p chromosome deletion mean that I have IMD107?
Not automatically. A large 5p deletion, including Cri-du-chat syndrome, affects many genes and has a different clinical context; if the deletion includes OTULIN, genetics and immunology review may be appropriate.

Get notified when new evidence is published on immunodeficiency 107, susceptibility to invasive staphylococcus aureus infection.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (9)
  1. 1

    Human OTULIN haploinsufficiency impairs cell-intrinsic immunity to staphylococcal α-toxin.

    Spaan AN, Neehus AL, Laplantine E, et al.

    Science (New York, N.Y.) 2022; (376(6599)):eabm6380 doi:10.1126/science.abm6380.

    PMID: 35587511
  2. 2

    OTULIN haploinsufficiency predisposes to environmentally directed inflammation.

    Staels F, Bücken L, De Vuyst L, et al.

    Frontiers in immunology 2024; (15()):983686 doi:10.3389/fimmu.2024.983686.

    PMID: 38827742
  3. 3

    Novel genotypes, phenotypes, and triggers in humans with OTULIN haploinsufficiency.

    van der Linden TJ, Arts RJW, Biggs CM, et al.

    Journal of human immunity 2025; (1(4)) doi:10.70962/jhi.20250018.

    PMID: 41293556
  4. 4

    OTULIN-related conditions: Report of a new case and review of the literature using GenIA.

    Caballero-Oteyza A, Crisponi L, Peng XP, et al.

    Research square 2024; doi:10.21203/rs.3.rs-3950863/v2.

    PMID: 38712244
  5. 5

    Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease.

    Zhou Q, Yu X, Demirkaya E, et al.

    Proceedings of the National Academy of Sciences of the United States of America 2016; (113(36)):10127-32 doi:10.1073/pnas.1612594113.

    PMID: 27559085
  6. 6

    Compound heterozygous variants in OTULIN are associated with fulminant atypical late-onset ORAS.

    Zinngrebe J, Moepps B, Monecke T, et al.

    EMBO molecular medicine 2022; (14(3)):e14901 doi:10.15252/emmm.202114901.

    PMID: 35170849
  7. 7

    Staphylococcus aureus, phagocyte NADPH oxidase and chronic granulomatous disease.

    Buvelot H, Posfay-Barbe KM, Linder P, et al.

    FEMS microbiology reviews 2017; (41(2)):139-157 doi:10.1093/femsre/fuw042.

    PMID: 27965320
  8. 8

    The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency.

    Engelhardt KR, Gertz ME, Keles S, et al.

    The Journal of allergy and clinical immunology 2015; (136(2)):402-12.

    PMID: 25724123
  9. 9

    Hyper-IgE syndromes in pediatrics: clinical spectrum, differential diagnosis, and management.

    Mikulić S, Mihaljević MV, Kraljević D

    Folia medica 2026; (68(4)) doi:10.3897/folmed.68.e173262.

    PMID: 42677762

This page explains the OTULIN-related biology and inherited risk behind IMD107 for informational purposes only and does not constitute medical advice. Ask a clinical immunologist or genetics professional to interpret your test results and infection risk.